BRIEF-FDA approves Boehringer Ingelheim's Jardiance for type 2 diabetes
August 01, 2014 at 11:33 AM EDT
Aug 1 (Reuters) - The U.S. Food and Drug Administrarion: * FDA approves Boehringer Ingelheim Pharmaceuticals' Jardiance to treat type 2
